Literature DB >> 10799608

Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions.

L X Liu1, N Heveker, O T Fackler, S Arold, S Le Gall, K Janvier, B M Peterlin, C Dumas, O Schwartz, S Benichou, R Benarous.   

Abstract

Nef is a myristoylated protein of 27 to 35 kDa that is conserved in primate lentiviruses. In vivo, Nef is required for high viral load and full pathological effects. In vitro, Nef has at least four activities: induction of CD4 and major histocompatibility complex (MHC) class I downregulation, enhancement of viral infectivity, and alteration of T-cell activation pathways. We previously reported that the Nef protein from human immunodeficiency virus type 1 interacts with a novel human thioesterase (hTE). In the present study, by mutational analysis, we identified a region of the Nef core, extending from the residues D108 to W124, that is involved both in Nef-hTE interaction and in Nef-induced CD4 downregulation. This region of Nef is located on the oligomer interface and is in close proximity to the putative CD4 binding site. One of the mutants carrying a mutation in this region, targeted to the conserved residue D123, was also found to be defective in two other functions of Nef, MHC class I downmodulation and enhancement of viral infectivity. Furthermore, mutation of this residue affected the ability of Nef to form dimers, suggesting that the oligomerization of Nef may be critical for its multiple functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799608      PMCID: PMC110886          DOI: 10.1128/jvi.74.11.5310-5319.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis.

Authors:  M Wiskerchen; C Cheng-Mayer
Journal:  Virology       Date:  1996-10-01       Impact factor: 3.616

2.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

3.  A novel acyl-CoA thioesterase enhances its enzymatic activity by direct binding with HIV Nef.

Authors:  H Watanabe; T Shiratori; H Shoji; S Miyatake; Y Okazaki; K Ikuta; T Sato; T Saito
Journal:  Biochem Biophys Res Commun       Date:  1997-09-08       Impact factor: 3.575

Review 4.  The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors.

Authors:  V Piguet; O Schwartz; S Le Gall; D Trono
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

5.  The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.

Authors:  S Arold; P Franken; M P Strub; F Hoh; S Benichou; R Benarous; C Dumas
Journal:  Structure       Date:  1997-10-15       Impact factor: 5.006

6.  Human immunodeficiency virus type 1 Nef protein on the cell surface is cytocidal for human CD4+ T cells.

Authors:  Y Fujii; K Otake; M Tashiro; A Adachi
Journal:  FEBS Lett       Date:  1996-09-09       Impact factor: 4.124

7.  Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.

Authors:  M Bouhamdan; S Benichou; F Rey; J M Navarro; I Agostini; B Spire; J Camonis; G Slupphaug; R Vigne; R Benarous; J Sire
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Fusion from without directed by human immunodeficiency virus particles.

Authors:  F Clavel; P Charneau
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain.

Authors:  X N Xu; B Laffert; G R Screaton; M Kraft; D Wolf; W Kolanus; J Mongkolsapay; A J McMichael; A S Baur
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Structure--function relationships in HIV-1 Nef.

Authors:  M Geyer; O T Fackler; B M Peterlin
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

2.  Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.

Authors:  Maya Williams; Jeremiah F Roeth; Matthew R Kasper; Rebekah I Fleis; Chris G Przybycin; Kathleen L Collins
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages.

Authors:  Lue Dai; Mario Stevenson
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

5.  Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.

Authors:  Andrea Crotti; Francesca Neri; Davide Corti; Silvia Ghezzi; Silvia Heltai; Andreas Baur; Guido Poli; Elena Santagostino; Elisa Vicenzi
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

6.  Synthesis and structure-activity analysis of diphenylpyrazolodiazene inhibitors of the HIV-1 Nef virulence factor.

Authors:  Prema C Iyer; Jielu Zhao; Lori A Emert-Sedlak; Kerry K Moore; Thomas E Smithgall; Billy W Day
Journal:  Bioorg Med Chem Lett       Date:  2014-02-26       Impact factor: 2.823

7.  Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.

Authors:  Eduardo O'Neill; Lillian S Kuo; John F Krisko; Diana R Tomchick; J Victor Garcia; John L Foster
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Type III Interferon Restriction by Porcine Epidemic Diarrhea Virus and the Role of Viral Protein nsp1 in IRF1 Signaling.

Authors:  Qingzhan Zhang; Hanzhong Ke; Anthony Blikslager; Takashi Fujita; Dongwan Yoo
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 9.  Small molecule inhibitors of the HIV-1 virulence factor, Nef.

Authors:  Thomas E Smithgall; Gary Thomas
Journal:  Drug Discov Today Technol       Date:  2013-12

10.  Development and validation of a high-content bimolecular fluorescence complementation assay for small-molecule inhibitors of HIV-1 Nef dimerization.

Authors:  Jerrod A Poe; Laura Vollmer; Andreas Vogt; Thomas E Smithgall
Journal:  J Biomol Screen       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.